CHU de Strasbourg -Hôpital de Hautepierre — Strasbourg

Public research footprint of CHU de Strasbourg -Hôpital de Hautepierre, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

CIDP - Chronic Inflammatory Demyelinating Polyneuropathy · Developmental and Epileptic Encephalopathy · Multifocal Motor Neuropathy (MMN) · Acute Respiratory Failure

Recently updated registry entries

NCT06660394 — A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With… (Recruiting)
NCT06920004 — A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP (Recruiting)
NCT06908226 — A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic… (Enrolling By Invitation)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at CHU de Strasbourg -Hôpital de Hautepierre?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.